UBS Group AG - SILO PHARMA INC ownership

SILO PHARMA INC's ticker is and the CUSIP is 82711P201. A total of 5 filers reported holding SILO PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SILO PHARMA INC
ValueSharesWeighting
Q4 2022$17,502
-52.7%
5,209
-23.4%
0.00%
Q3 2022$37,0006,7990.00%
Other shareholders
SILO PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Financial Advocates Investment Management 57,307$95,7030.01%
Westside Investment Management, Inc. 94$1570.00%
VANGUARD GROUP INC 14,504$24,2220.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 16,179$26,6950.00%
STATE STREET CORP 12,500$20,6250.00%
WELLS FARGO & COMPANY/MN 19$320.00%
Tower Research Capital LLC (TRC) 4,890$8,1660.00%
FWL INVESTMENT MANAGEMENT, LLC 80$1340.00%
View complete list of SILO PHARMA INC shareholders